US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Clarus Corporation - Common Stock (NQ:CLAR)

3.450 +0.070 (+2.07%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarus Corporation - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Special Committee of Clarus Retains Houlihan Lokey as Financial Advisor
From Clarus Corporation
Via GlobeNewswire
News headline image
Clarus Confirms Receipt of Non-Binding Indication of Interest Regarding Precision Sport Segment
From Clarus Corporation
Via GlobeNewswire
News headline image
Analyst Ratings for Clarus ↗
 
Via Benzinga
News headline image
Clarus's Ex-Dividend Date Is Friday, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Earnings Preview: Clarus ↗
 
Via Benzinga
News headline image
Expert Ratings for Clarus ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Clarus ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Fostering Confidence: Clarus Reliable Progress and Investor Expectations ↗
Today, August 25, 2023, marks an important moment for investors of Clarus (NASDAQ:CLAR). The company will distribute a dividend payout of $0.03 per share, demonstrating an annualized dividend yield of... 
Via Benzinga
News headline image
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
Via Benzinga
News headline image
Clarus: Dividend Insights ↗
 
Via Benzinga
News headline image
Clarus Earnings Preview ↗
 
Via Benzinga
News headline image
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Clarus Reports Second Quarter 2023 Results
From Clarus Corporation
Via GlobeNewswire
News headline image
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
News headline image
Clarus Sets Second Quarter 2023 Conference Call for Monday, August 7, 2023, at 5:00 p.m. ET
From Clarus Corporation
Via GlobeNewswire
News headline image
Clarus's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Friday Is Your Last Chance To Buy Clarus Before The Dividend Payout ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023 ↗
 
Via Benzinga
News headline image
Clarus Announces June Investor Conference Schedule
From Clarus Corporation
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023 ↗
 
Via Benzinga
News headline image
Clarus Reports First Quarter 2023 Results
From Clarus Corporation
Via GlobeNewswire
News headline image
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
News headline image
Clarus Sets First Quarter 2023 Conference Call for Monday, May 1, 2023, at 5:00 p.m. ET
From Clarus Corporation
Via GlobeNewswire
News headline image
10 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 1, 2023 ↗
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
News headline image
Clarus Announces March Investor Conference Schedule
From Clarus Corporation
Via GlobeNewswire
News headline image
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Clarus Reports Fourth Quarter and Full Year 2022 Results
From Clarus Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For February 27, 2023 ↗
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >